Earnings Per Share, Diluted of Emmaus Life Sciences, Inc. from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
Emmaus Life Sciences, Inc. quarterly and annual Earnings Per Share, Diluted in USD/shares history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • Emmaus Life Sciences, Inc. Earnings Per Share, Diluted for the quarter ending 30 Sep 2025 was -0.03, a 200% decline year-over-year.
  • Emmaus Life Sciences, Inc. Earnings Per Share, Diluted for the twelve months ending 30 Sep 2025 was 0, a 300% decline year-over-year.
  • Emmaus Life Sciences, Inc. annual Earnings Per Share, Diluted for 2024 was -0.1, a 43% decline from 2023.
  • Emmaus Life Sciences, Inc. annual Earnings Per Share, Diluted for 2023 was -0.07, a 67% increase from 2022.
  • Emmaus Life Sciences, Inc. annual Earnings Per Share, Diluted for 2022 was -0.21, a 34% increase from 2021.
Source SEC data
View on sec.gov
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Change (%)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Change (%)

Emmaus Life Sciences, Inc. Quarterly Earnings Per Share, Diluted (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 0 -0.03 -0.06 -200% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 0 -0.02 +0.01 +33% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 0 -0.04 +0.03 +43% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 0 -0.03 -0.07 -175% 01 Oct 2024 31 Dec 2024 10-K 14 Apr 2025 2024 FY
Q3 2024 0 0.03 +0.04 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 0 -0.03 0 0% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 0 -0.07 0 0% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 0 0.04 +0.03 +300% 01 Oct 2023 31 Dec 2023 10-K 14 Apr 2025 2024 FY
Q3 2023 0 -0.01 0 0% 01 Jul 2023 30 Sep 2023 10-Q 19 Nov 2024 2024 Q3
Q2 2023 0 -0.03 +0.15 +83% 01 Apr 2023 30 Jun 2023 10-Q 10 Sep 2024 2024 Q2
Q1 2023 0 -0.07 -0.04 -133% 01 Jan 2023 31 Mar 2023 10-Q 10 Sep 2024 2024 Q1
Q4 2022 0 0.01 01 Oct 2022 31 Dec 2022 10-K 03 Jul 2024 2023 FY
Q3 2022 -0.01 +0.05 +83% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 -0.18 -0.23 -460% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 -0.03 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q3 2021 -0.06 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 0.05 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q3 2019 -0.6 -0.47 -362% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q3 2018 -0.13 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019 2019 Q3
Q1 2015 -0.01 0 0% 01 Jan 2015 31 Mar 2015 10-Q 18 May 2015 2015 Q2
Q4 2014 -0.01 -0.01 01 Oct 2014 31 Dec 2014 10-Q 13 Feb 2015 2015 Q1
Q1 2014 0 -0.01 +0.06 +86% 01 Jan 2014 31 Mar 2014 10-Q 18 May 2015 2015 Q2
Q4 2013 0 0 +0.48 01 Oct 2013 31 Dec 2013 10-Q 13 Feb 2015 2015 Q1
Q3 2013 0 0.44 -3.18 -88% 01 Jul 2013 30 Sep 2013 10-K 23 Dec 2013 2013 FY
Q2 2013 3 -0.03 -0.54 -106% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2013 2013 Q3
Q1 2013 3 -0.07 +4.41 +98% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014 2014 Q2
Q4 2012 0 -0.48 +0.98 +67% 01 Oct 2012 31 Dec 2012 10-Q 13 Feb 2014 2014 Q1
Q3 2012 -1 3.62 +4.86 01 Jul 2012 30 Sep 2012 10-K 23 Dec 2013 2013 FY
Q2 2012 -6 0.51 +0.29 +132% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013 2013 Q3
Q1 2012 -6 -4.48 -0.76 -20% 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013 2013 Q2
Q4 2011 -6 -1.46 -1.46 01 Oct 2011 31 Dec 2011 10-Q/A 22 Feb 2013 2013 Q1
Q3 2011 -4 -1.24 01 Jul 2011 30 Sep 2011 10-K 15 Jan 2013 2012 FY
Q2 2011 0.22 +0.25 01 Apr 2011 30 Jun 2011 10-Q/A 11 Sep 2012 2012 Q3
Q1 2011 -3.72 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012 2012 Q2
Q4 2010 0 01 Oct 2010 31 Dec 2010 10-Q 14 Feb 2012 2012 Q1
Q2 2010 -0.03 01 Apr 2010 30 Jun 2010 10-Q/A 09 Sep 2011 2011 Q3

Emmaus Life Sciences, Inc. Annual Earnings Per Share, Diluted (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 -0.1 -0.03 -43% 01 Jan 2024 31 Dec 2024 10-K 14 Apr 2025 2024 FY
2023 -0.07 +0.14 +67% 01 Jan 2023 31 Dec 2023 10-K 14 Apr 2025 2024 FY
2022 -0.21 +0.11 +34% 01 Jan 2022 31 Dec 2022 10-K 03 Jul 2024 2023 FY
2021 -0.32 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2013 -0.14 +1.67 +92% 01 Oct 2012 30 Sep 2013 10-K 23 Dec 2013 2013 FY
2012 -1.81 +2.93 +62% 01 Oct 2011 30 Sep 2012 10-K 23 Dec 2013 2013 FY
2011 -4.74 -4.58 -2862% 01 Oct 2010 30 Sep 2011 10-K 15 Jan 2013 2012 FY
2010 -0.16 01 Oct 2009 30 Sep 2010 10-K 22 Dec 2011 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.